Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Businessweek Archives

J&J Returns To The U.S. Iud Market


In Business This Week

J&J RETURNS TO THE U.S. IUD MARKET

EVER SINCE A.H. ROBINS' Dalkon Shield proved harmful to thousands of women, Johnson & Johnson has steered clear of the U.S. intrauterine device market--even as its IUD sales boomed overseas. On July 28, though, J&J quietly acquired GynoPharma, which has marketed the ParaGard copper IUD in the U.S. since 1988. GynoPharma CEO Roderick Mackenzie sees the deal as vindication. "People thought I was crazy when I put the IUD on the market," he says. Mackenzie plans to develop more women's products through a new outfit, Gynetics.EDITED BY KEITH H. HAMMONDS


LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus